Clinical Trial Update: FREERIDE STUDY, Freeway Paclitaxel Coated Balloon Catheter to Treat Peripheral Artery Disease [Phase 3]

View source ↗

Summary

This document reports a Phase 3 update on the FREERIDE study evaluating the Freeway Paclitaxel-coated balloon catheter for treating Peripheral Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Freeway Paclitaxel-Coated Balloon Catheter (paclitaxel-coated balloon catheter)

Snippet

Sponsor: Eurocor GmbH | Conditions: Peripheral Artery Disease | Phase 3 | Status: UNKNOWN